JUL 24, 2020 12:46 PM PDT

A New Biomarker Candidate for Cancer Diagnostics

WRITTEN BY: Jasper Cantrell

One of the best tools in the fight against cancer is diagnostics. In 2018, colorectal cancer was the second most lethal cancer in the world due to a lack of effective diagnostic tools. It is often not caught until it reaches later stages, where treatments are less impactful.

Modern diagnostics identify diseases and their severity by following biomarkers. Biomarkers are genes, proteins, or other factors with abnormal expression levels in diseases compared to healthy tissues. In cancer, this type of diagnostic method has become popular in the research. Future diagnostic tools will be able to identify a disease and identify the best way to treat it.

A recent screening study in colorectal cancer found that the protein transcobalamin 1 is abnormally expressed. This protein has various cellular roles and has been found in high levels in several types of cancer. A team from the Hebei Medical University in China decided to investigate this biomarker candidate to diagnose colorectal cancer.  

The team began by confirming that transcobalamin 1 is overexpressed in colorectal patients versus healthy tissue. Statistical analysis revealed it was strongly associated with a poor prognosis and late stages of colorectal cancer. These observations indicate transcobalamin 1 may act as a good diagnostic marker for colorectal cancer. On top of that, there was a distinct decrease in transcobalamin 1 levels after being treated with chemotherapy.

The team then examined how transcobalamin 1 acted as a tumor promoter. Computational analysis showed that many proteins involved in pro-tumor signaling were upregulated alongside transcobalamin 1. They could not further elaborate, however.

In this study, transcobalamin 1 proved to be a strong candidate for a diagnostic biomarker. It was clearly overexpressed in colorectal cancers, and this expression decreased upon undergoing chemotherapy showing it has potential as a chemosensitivity marker. How it works as a pro-tumor factor remains unknown, however.

The team concludes, “Taken together, we conclude that TCN1 expression is significantly overexpressed in colon cancer and is correlated with advanced pathological features. TCN1 may be a predictor of prognosis and a potential biomarker for predicting chemosensitivity.”

Sources: Nature Scientific Reports, U.S. Food and Drug Administration

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
OCT 06, 2020
Cannabis Sciences
Cannabis Use May Reduce Cancer Risk by 10%
OCT 06, 2020
Cannabis Use May Reduce Cancer Risk by 10%
A recent meta-analysis of 34 studies found that cannabis use may decrease one’s risk of developing certain kinds o ...
OCT 08, 2020
Cancer
Oral cancer pain levels indicate metastasis
OCT 08, 2020
Oral cancer pain levels indicate metastasis
A new study from NYU College of Dentistry researchers provides insight as to why patients with metastatic oral cancer ex ...
OCT 09, 2020
Cancer
Cloud technology cuts improve efficiency for cancer nurses
OCT 09, 2020
Cloud technology cuts improve efficiency for cancer nurses
In a new study reported in Clinical Cancer Informatics, an American Society of Clinical Oncology journal, medical provid ...
OCT 18, 2020
Microbiology
Mouth Microbes Play a Role in Oral Cancer Development
OCT 18, 2020
Mouth Microbes Play a Role in Oral Cancer Development
Oral hygiene is not only important for keeping teeth and gums healthy; it can also affect a person's health in general.
OCT 18, 2020
Cancer
Virus-mimicking drug attacks melanoma tumors
OCT 18, 2020
Virus-mimicking drug attacks melanoma tumors
Research published recently in the journal Science Translational Medicine from scientists at the UCLA Jonsson Compr ...
Loading Comments...